Market World Bone Densitometers Market | Page 3

stage. The aforementioned factors are predicted to positively impact the segment growth during the forecast period. Regional Insights The market was dominated by North American region in 2016 owing to the rising osteoporosis burden of the region. Various strategic initiatives by prominent market players for improvement of R&D capabilities and maintaining high medical standards are anticipated to drive the regional demand. The growth across Asia Pacific region is expected to be exponential throughout the forecast period with a CAGR of xx%. The high growth can be attributed to the rise in demand to reduce the existing prevalence, increased disposable income and improvements is infrastructure of healthcare facilities. The developing economies including China and India presents a potential growth opportunity in the forecast period owing to the high awareness level related to osteoporosis care. Competitive Insights The intensive competition in the industry is expected to rise throughout the forecast period as a consequence of increasing number of strategic initiatives such as new product development, R&D investments, acquisitions and mergers by prominent market players to maintain their competitive edge over the other companies. For example, Hologic, Inc. in August 2014 received regulatory approval for horizon DXA platform in Canada having workflow efficiencies and enhanced technical capabilities. The integrated ceramic detector array and high resolution achieved by the devices helps in enhanced stability, precision, image quality and skeletal mapping. Market Segment: Bone Densitometers Technology Outlook (Revenue, USD Million, 2014 - 2025) • Axial Bone Densitometry • Dual Energy X-Ray Absorptiometry (DEXA) • Quantitative Computed Tomography (QCT) • Peripheral Bone Densitometry • Single Energy X-Ray Absorptiometry (SEXA) • Dual Energy X-Ray Absorptiometry (PDEXA) • Radiographic Absorptiometry (RA) • Quantitative Ultrasound (QUS) • Peripheral Quantitative Computed Tomography (pQCT)